{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T08:14:14Z","timestamp":1793434454606,"version":"4.5.0"},"reference-count":258,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN-2025-05,188"],"award-info":[{"award-number":["RGPIN-2025-05,188"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009192","name":"Alberta Innovates","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009192","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["203698"],"award-info":[{"award-number":["203698"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["SI-1"],"award-info":[{"award-number":["SI-1"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["CT-4"],"award-info":[{"award-number":["CT-4"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["192039"],"award-info":[{"award-number":["192039"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["183664"],"award-info":[{"award-number":["183664"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009056","name":"Canadian Glycomics Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009056","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jbc.2026.111249","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:48:52Z","timestamp":1770252532000},"page":"111249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Writers and readers of sialylation in immunoregulation in cancer"],"prefix":"10.1016","volume":"302","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9077-5744","authenticated-orcid":false,"given":"Mathieu","family":"Decloquement","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4579-1048","authenticated-orcid":false,"given":"Matthew S.","family":"Macauley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2026.111249_bib1","series-title":"Sialic Acids and Other Nonulosonic Acids in Essentials of Glycobiology","first-page":"185","author":"Lewis","year":"2022"},{"key":"10.1016\/j.jbc.2026.111249_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2025.101978","article-title":"Discovery and characterization of vertebrate sialoglycan-binding proteins","volume":"79","author":"Adler","year":"2025","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.jbc.2026.111249_bib3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3390\/cancers10060207","article-title":"Hypersialylation in cancer: modulation of inflammation and therapeutic opportunities","volume":"10","author":"Rodrigues","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jbc.2026.111249_bib4","doi-asserted-by":"crossref","first-page":"4248","DOI":"10.3390\/cancers14174248","article-title":"Aberrant sialylation in cancer: therapeutic opportunities","volume":"14","author":"Munkley","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jbc.2026.111249_bib5","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M112.017558","article-title":"Metabolic flux increases glycoprotein sialylation: implications for cell adhesion and cancer metastasis","volume":"11","author":"Almaraz","year":"2012","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.jbc.2026.111249_bib6","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2478\/fco-2021-0006","article-title":"Sialic acids: an avenue to target cancer progression, metastasis, and resistance to therapy","volume":"12","author":"Goni","year":"2021","journal-title":"Forum Clin. Oncol."},{"key":"10.1016\/j.jbc.2026.111249_bib7","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41563-024-01822-2","article-title":"A thicker skin for better immune evasion","volume":"23","author":"Schmidt","year":"2024","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jbc.2026.111249_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2024.101925","article-title":"Roles for Siglec-glycan interactions in regulating immune cells","volume":"77","author":"Lin","year":"2025","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.jbc.2026.111249_bib9","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s11596-025-00041-3","article-title":"Aberrant sialylation in ovarian cancer: orchestrating progression, metastasis, and therapeutic hurdles","volume":"45","author":"Chen","year":"2025","journal-title":"Curr. Med. Sci."},{"key":"10.1016\/j.jbc.2026.111249_bib10","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.3389\/fimmu.2019.02120","article-title":"Altered cell adhesion and glycosylation promote cancer immune suppression and metastasis","volume":"10","author":"Laubli","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jbc.2026.111249_bib11","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s00018-014-1799-5","article-title":"Cancer intelligence acquired (CIA): tumor glycosylation and sialylation codes dismantling antitumor defense","volume":"72","author":"Boligan","year":"2015","journal-title":"Cell Mol. Life. Sci."},{"key":"10.1016\/j.jbc.2026.111249_bib12","first-page":"102","article-title":"Targeting aberrant sialylation to treat cancer","volume":"6","author":"Munkley","year":"2019","journal-title":"Medicines (Basel)"},{"key":"10.1016\/j.jbc.2026.111249_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.799861","article-title":"The distinct roles of sialyltransferases in cancer biology and onco-immunology","volume":"12","author":"Hugonnet","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jbc.2026.111249_bib14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3390\/ijms17030275","article-title":"The role of Sialyl-Tn in cancer","volume":"17","author":"Munkley","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2026.111249_bib15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.semcancer.2010.04.005","article-title":"Selectins promote tumor metastasis","volume":"20","author":"Laubli","year":"2010","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.jbc.2026.111249_bib16","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cellimm.2018.03.007","article-title":"Glycosylation in cancer: selected roles in tumour progression, immune modulation and metastasis","volume":"333","author":"Rodrigues","year":"2018","journal-title":"Cell Immunol."},{"key":"10.1016\/j.jbc.2026.111249_bib17","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2741\/e396","article-title":"Sialyltransferases functions in cancers","volume":"4","author":"Harduin-Lepers","year":"2012","journal-title":"Front. Biosci."},{"key":"10.1016\/j.jbc.2026.111249_bib18","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jcmgh.2015.12.003","article-title":"Glycans related to the CA19-9 antigen are elevated in distinct subsets of pancreatic cancers and improve diagnostic accuracy over CA19-9","volume":"2","author":"Tang","year":"2016","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jbc.2026.111249_bib19","first-page":"1033","article-title":"Carcinoembryonic antigen is a sialyl Lewis x\/a carrier and an E-selectin ligand in non-small cell lung cancer","volume":"55","author":"Ferreira","year":"2019","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.jbc.2026.111249_bib20","first-page":"16","article-title":"Selectin ligands sialyl-lewis a and sialyl-lewis x in gastrointestinal cancers","volume":"6","author":"Trinchera","year":"2017","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.jbc.2026.111249_bib21","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s12253-015-0033-6","article-title":"Sialylation: an avenue to target cancer cells","volume":"22","author":"Vajaria","year":"2016","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.jbc.2026.111249_bib22","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/283497","article-title":"Towards in vivo imaging of cancer sialylation","volume":"2011","author":"Martinez-Duncker","year":"2011","journal-title":"Int. J. Mol. Imaging"},{"key":"10.1016\/j.jbc.2026.111249_bib23","doi-asserted-by":"crossref","first-page":"4498","DOI":"10.1158\/0008-5472.CAN-03-3614","article-title":"Loss of disialyl Lewis(a), the ligand for lymphocyte inhibitory receptor sialic acid-binding immunoglobulin-like lectin-7 (Siglec-7) associated with increased sialyl Lewis(a) expression on human colon cancers","volume":"64","author":"Miyazaki","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2026.111249_bib24","doi-asserted-by":"crossref","first-page":"22787","DOI":"10.1074\/jbc.M211034200","article-title":"Synthesis of disialyl Lewis a (Le(a)) structure in colon cancer cell lines by a sialyltransferase, ST6GalNAc VI, responsible for the synthesis of alpha-series gangliosides","volume":"278","author":"Tsuchida","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111249_bib25","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.bbagen.2015.12.016","article-title":"Glycomic analysis of gastric carcinoma cells discloses glycans as modulators of RON receptor tyrosine kinase activation in cancer","volume":"1860","author":"Mereiter","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jbc.2026.111249_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2024.100776","article-title":"(Sialyl)Lewis antigen expression on glycosphingolipids, N-, and O-Glycans in colorectal cancer cell lines is linked to a colon-like differentiation program","volume":"23","author":"Wang","year":"2024","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.jbc.2026.111249_bib27","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1476-4598-13-129","article-title":"MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress","volume":"13","author":"Felder","year":"2014","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jbc.2026.111249_bib28","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/(SICI)1097-0215(19960315)65:6<833::AID-IJC21>3.0.CO;2-3","article-title":"Functional role of sialyl Lewis X and fibronectin-derived RGDS peptide analogue on tumor-cell arrest in lungs followed by extravasation","volume":"65","author":"Saiki","year":"1996","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jbc.2026.111249_bib29","doi-asserted-by":"crossref","first-page":"27213","DOI":"10.1074\/jbc.271.44.27213","article-title":"6'-Sulfo sialyl Lex but not 6-sulfo sialyl Lex expressed on the cell surface supports L-selectin-mediated adhesion","volume":"271","author":"Tsuboi","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111249_bib30","doi-asserted-by":"crossref","first-page":"E4170","DOI":"10.1073\/pnas.1602214113","article-title":"Structural basis for sulfation-dependent self-glycan recognition by the human immune-inhibitory receptor Siglec-8","volume":"113","author":"Propster","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.111249_bib31","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1021\/acschembio.3c00664","article-title":"Unraveling molecular recognition of Glycan ligands by Siglec-9 via NMR spectroscopy and molecular dynamics modeling","volume":"19","author":"Atxabal","year":"2024","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jbc.2026.111249_bib32","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.bbagen.2013.09.036","article-title":"The expanding roles of the Sd(a)\/Cad carbohydrate antigen and its cognate glycosyltransferase B4GALNT2","volume":"1840","author":"Dall'Olio","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jbc.2026.111249_bib33","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1002\/cbic.202100363","article-title":"B4GALNT2 controls Sd(a) and SLe(x) antigen biosynthesis in healthy and cancer human colon","volume":"22","author":"Groux-Degroote","year":"2021","journal-title":"ChemBioChem"},{"key":"10.1016\/j.jbc.2026.111249_bib34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0009-8981(01)00644-1","article-title":"AFP-L3: a new generation of tumor marker for hepatocellular carcinoma","volume":"313","author":"Li","year":"2001","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jbc.2026.111249_bib35","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000027673","article-title":"AFP-L3 for the diagnosis of early hepatocellular carcinoma: a meta-analysis","volume":"100","author":"Zhou","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jbc.2026.111249_bib36","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1074\/jbc.M511826200","article-title":"The ST6GalNAc-I sialyltransferase localizes throughout the Golgi and is responsible for the synthesis of the tumor-associated sialyl-Tn O-glycan in human breast cancer","volume":"281","author":"Sewell","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111249_bib37","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.canlet.2006.08.010","article-title":"Biological significance of cancer-associated sialyl-Tn antigen: modulation of malignant phenotype in gastric carcinoma cells","volume":"249","author":"Pinho","year":"2007","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jbc.2026.111249_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1466255","article-title":"Sialyl-Tn glycan epitope as a target for pancreatic cancer therapies","volume":"14","author":"Abrantes","year":"2024","journal-title":"Front Oncol."},{"key":"10.1016\/j.jbc.2026.111249_bib39","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0925-4439(99)00055-1","article-title":"MUC1 and cancer","volume":"1455","author":"Taylor-Papadimitriou","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jbc.2026.111249_bib40","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s10719-014-9548-4","article-title":"Overexpression of alpha2,3sialyl T-antigen in breast cancer determined by miniaturized glycosyltransferase assays and confirmed using tissue microarray immunohistochemical analysis","volume":"31","author":"Patil","year":"2014","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.jbc.2026.111249_bib41","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.3390\/ijms22041972","article-title":"Cracking the breast cancer Glyco-code through glycan-lectin interactions: targeting immunosuppressive macrophages","volume":"22","author":"Lopes","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2026.111249_bib42","doi-asserted-by":"crossref","first-page":"4999","DOI":"10.3390\/cancers14204999","article-title":"Identification of the O-Glycan epitope targeted by the anti-human carcinoma monoclonal antibody (mAb) NEO-201","volume":"14","author":"Tsang","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jbc.2026.111249_bib43","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2015024118","article-title":"Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7","volume":"118","author":"Wisnovsky","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.111249_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.111139","article-title":"Bidirectional signals generated by Siglec-7 and its crucial ligand tri-sialylated T to escape of cancer cells from immune surveillance","volume":"27","author":"Hashimoto","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.jbc.2026.111249_bib45","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0145-2126(01)00036-4","article-title":"A minor E-selectin ligand, CD65, is critical for extravascular infiltration of acute myeloid leukemia cells","volume":"25","author":"Noguchi","year":"2001","journal-title":"Leuk. Res."},{"key":"10.1016\/j.jbc.2026.111249_bib46","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/oxfordjournals.annonc.a058934","article-title":"Fucosyl-GM1 in small-cell lung cancer. A comparison with the tumour marker neuron-specific enolase","volume":"5","author":"Drivsholm","year":"1994","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jbc.2026.111249_bib47","first-page":"300","article-title":"Dysregulated expression of glycolipids in tumor cells: from negative modulator of anti-tumor immunity to promising targets for developing therapeutic agents","volume":"5","author":"Daniotti","year":"2015","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jbc.2026.111249_bib48","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10719-018-09856-w","article-title":"Identification of 9-O-acetyl-N-acetylneuraminic acid (Neu5,9Ac(2)) as main O-acetylated sialic acid species of GD2 in breast cancer cells","volume":"36","author":"Cavdarli","year":"2019","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.jbc.2026.111249_bib49","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3390\/cells9030741","article-title":"O-acetylated gangliosides as targets for cancer immunotherapy","volume":"9","author":"Cavdarli","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jbc.2026.111249_bib50","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3389\/fonc.2013.00306","article-title":"Glycosylation of glycolipids in cancer: basis for development of novel therapeutic approaches","volume":"3","author":"Daniotti","year":"2013","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jbc.2026.111249_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101643","article-title":"N-glycolylneuraminic acid as a carbohydrate cancer biomarker","volume":"31","author":"Wang","year":"2023","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.jbc.2026.111249_bib52","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/glycob\/cwv097","article-title":"Sialic acids in cancer biology and immunity","volume":"26","author":"Pearce","year":"2016","journal-title":"Glycobiology"},{"key":"10.1016\/j.jbc.2026.111249_bib53","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-42095-0","article-title":"Salmonid polysialyltransferases to generate a variety of sialic acid polymers","volume":"13","author":"Decloquement","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2026.111249_bib54","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.3389\/fimmu.2018.02885","article-title":"Possible influences of endogenous and exogenous ligands on the evolution of human siglecs","volume":"9","author":"Angata","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jbc.2026.111249_bib55","first-page":"779","article-title":"Polysialic acid on the neural cell adhesion molecule correlates with expression of polysialyltransferases and promotes neuroblastoma cell growth","volume":"58","author":"Hildebrandt","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2026.111249_bib56","first-page":"297","article-title":"Polysialic acid of the neural cell adhesion molecule distinguishes small cell lung carcinoma from carcinoids","volume":"139","author":"Komminoth","year":"1991","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jbc.2026.111249_bib57","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/glycob\/cwi071","article-title":"Polysialic acid facilitates tumor invasion by glioma cells","volume":"15","author":"Suzuki","year":"2005","journal-title":"Glycobiology"},{"key":"10.1016\/j.jbc.2026.111249_bib58","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41523-022-00442-w","article-title":"The different prognostic significance of polysialic acid and CD56 expression in tumor cells and lymphocytes identified in breast cancer","volume":"8","author":"Soukhtehzari","year":"2022","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.jbc.2026.111249_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/srep33026","article-title":"Polysialic acid sustains cancer cell survival and migratory capacity in a hypoxic environment","volume":"6","author":"Elkashef","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2026.111249_bib60","article-title":"Polysialic acid in the immune system","volume":"12","author":"Villanueva-Cabello","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jbc.2026.111249_bib61","first-page":"1666","article-title":"Prognostic significance of polysialic acid expression in resected non-small cell lung cancer","volume":"61","author":"Tanaka","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2026.111249_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.871757","article-title":"News and views on polysialic acid: from tumor progression and brain development to psychiatric disorders, neurodegeneration, Myelin repair and immunomodulation","volume":"10","author":"Thiesler","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jbc.2026.111249_bib63","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0300-9084(01)01301-3","article-title":"The human sialyltransferase family","volume":"83","author":"Harduin-Lepers","year":"2001","journal-title":"Biochimie"},{"key":"10.1016\/j.jbc.2026.111249_bib64","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s10719-023-10123-w","article-title":"The vertebrate sialylation machinery: structure-function and molecular evolution of GT-29 sialyltransferases","volume":"40","author":"Harduin-Lepers","year":"2023","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.jbc.2026.111249_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.carres.2024.109242","article-title":"Putting a cap on the glycome: dissecting human sialyltransferase functions","volume":"544","author":"Mohamed","year":"2024","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.jbc.2026.111249_bib66","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4137\/GBI.S3123","article-title":"Comprehensive analysis of sialyltransferases in vertebrate genomes","volume":"2","author":"Harduin-Lepers","year":"2010","journal-title":"Glycobiol. Insights"},{"key":"10.1016\/j.jbc.2026.111249_bib67","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/nsmb1109-1121","article-title":"Glycan terminator","volume":"16","author":"Paulson","year":"2009","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.jbc.2026.111249_bib68","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/S0006-291X(03)01314-7","article-title":"Transcriptional regulation of human beta-galactoside alpha2,6-sialyltransferase (hST6Gal I) gene in colon adenocarcinoma cell line","volume":"307","author":"Xu","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jbc.2026.111249_bib69","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/glycob\/10.6.623","article-title":"Transcriptional regulation of human beta-galactoside alpha2, 6-sialyltransferase (hST6Gal I) gene during differentiation of the HL-60 cell line","volume":"10","author":"Taniguchi","year":"2000","journal-title":"Glycobiology"},{"key":"10.1016\/j.jbc.2026.111249_bib70","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/glycob\/cwaa110","article-title":"Regulation of ST6GAL1 sialyltransferase expression in cancer cells","volume":"31","author":"Dorsett","year":"2021","journal-title":"Glycobiology"},{"key":"10.1016\/j.jbc.2026.111249_bib71","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1248\/bpb.29.2372","article-title":"NFkappaB-p65 dependent transcriptional regulation of glycosyltransferases in human colon adenocarcinoma HT-29 by stimulation with tumor necrosis factor alpha","volume":"29","author":"Higai","year":"2006","journal-title":"Biol. Pharm. Bull"},{"key":"10.1016\/j.jbc.2026.111249_bib72","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1006\/bbrc.2001.5709","article-title":"Gene structure and transcriptional regulation of human Gal beta1,4(3) GlcNAc alpha2,3-sialyltransferase VI (hST3Gal VI) gene in prostate cancer cell line","volume":"287","author":"Taniguchi","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jbc.2026.111249_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062559","article-title":"Estradiol represses the G(D3) synthase gene ST8SIA1 expression in human breast cancer cells by preventing NFkappaB binding to ST8SIA1 promoter","volume":"8","author":"Bobowski","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2026.111249_bib74","first-page":"1271","article-title":"The role of DNA methylation in ST6Gal1 expression in gliomas","volume":"26","author":"Kroes","year":"2016","journal-title":"Glycobiology"},{"key":"10.1016\/j.jbc.2026.111249_bib75","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1186\/1471-2407-14-901","article-title":"Epigenetic inactivation of ST6GAL1 in human bladder cancer","volume":"14","author":"Antony","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jbc.2026.111249_bib76","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1021\/acscentsci.2c00748","article-title":"High-throughput analysis reveals miRNA upregulating alpha-2,6-Sialic acid through direct miRNA-mRNA interactions","volume":"8","author":"Jame-Chenarboo","year":"2022","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.jbc.2026.111249_bib77","doi-asserted-by":"crossref","first-page":"14383","DOI":"10.1074\/jbc.RA119.009539","article-title":"Assembly of B4GALT1\/ST6GAL1 heteromers in the Golgi membranes involves lateral interactions via highly charged surface domains","volume":"294","author":"Khoder-Agha","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111249_bib78","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202500212","article-title":"Glycoproteins, glycolipids, or both: why do glycosyltransferases recognize different acceptors?","volume":"26","author":"Mikolajczyk","year":"2025","journal-title":"ChemBioChem"},{"key":"10.1016\/j.jbc.2026.111249_bib79","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1006\/bbrc.2000.2745","article-title":"Redefined substrate specificity of ST6GalNAc II: a second candidate sialyl-Tn synthase","volume":"272","author":"Kono","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jbc.2026.111249_bib80","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.bbagen.2005.12.012","article-title":"Probing the substrate specificity of four different sialyltransferases using synthetic beta-D-Galp-(14)-beta-D-GlcpNAc-(12)-alpha-D-Manp-(1O) (CH(2))7CH3)) analogues general activating effect of replacing N-acetylglucosamine by N-propionylglucosamine","volume":"1760","author":"Rohfritsch","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jbc.2026.111249_bib81","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.3390\/ijms17081286","article-title":"Phylogenetic-derived insights into the evolution of sialylation in eukaryotes: comprehensive analysis of vertebrate beta-Galactoside alpha2,3\/6-Sialyltransferases (ST3Gal and ST6Gal)","volume":"17","author":"Teppa","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2026.111249_bib82","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1107\/S0907444913015412","article-title":"The structure of human alpha-2,6-sialyltransferase reveals the binding mode of complex glycans","volume":"69","author":"Kuhn","year":"2013","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.jbc.2026.111249_bib83","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/glycob\/9.11.1213","article-title":"Cloning and expression of a human gene encoding an N-acetylgalactosamine-alpha2,6-sialyltransferase (ST6GalNAc I): a candidate for synthesis of cancer-associated sialyl-Tn antigens","volume":"9","author":"Ikehara","year":"1999","journal-title":"Glycobiology"},{"key":"10.1016\/j.jbc.2026.111249_bib84","doi-asserted-by":"crossref","first-page":"7050","DOI":"10.1158\/0008-5472.CAN-04-1921","article-title":"Role of the human ST6GalNAc-I and ST6GalNAc-II in the synthesis of the cancer-associated sialyl-Tn antigen","volume":"64","author":"Marcos","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2026.111249_bib85","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0304-4165(00)00020-9","article-title":"Molecular cloning and functional expression of human ST6GalNAc II. Molecular expression in various human cultured cells","volume":"1474","author":"Samyn-Petit","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jbc.2026.111249_bib86","doi-asserted-by":"crossref","first-page":"7952","DOI":"10.1073\/pnas.91.17.7952","article-title":"Expression cloning of a CMP-NeuAc:NeuAc alpha 2-3Gal beta 1-4Glc beta 1-1'Cer alpha 2,8-sialyltransferase (GD3 synthase) from human melanoma cells","volume":"91","author":"Nara","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.111249_bib87","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/cells14010009","article-title":"ST8SIA6 sialylates CD24 to enhance its membrane localization in BRCA","volume":"14","author":"He","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.jbc.2026.111249_bib88","doi-asserted-by":"crossref","first-page":"18594","DOI":"10.1074\/jbc.M910204199","article-title":"Differential biosynthesis of polysialic acid on neural cell adhesion molecule (NCAM) and oligosaccharide acceptors by three distinct alpha 2,8-sialyltransferases, ST8Sia IV (PST), ST8Sia II (STX), and ST8Sia III","volume":"275","author":"Angata","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111249_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118670","article-title":"The role of sialyltransferases in gynecological malignant tumors","volume":"263","author":"Zhang","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.jbc.2026.111249_bib90","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2026102118","article-title":"Probing the binding specificities of human siglecs by cell-based glycan arrays","volume":"118","author":"Bull","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.111249_bib91","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.pbiomolbio.2025.06.001","article-title":"The multifaceted roles of ST3GAL family in cancer: mechanistic insights and therapeutic implications","volume":"197","author":"Guo","year":"2025","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"10.1016\/j.jbc.2026.111249_bib92","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/s41419-018-1101-0","article-title":"Sialyltransferase ST3GAL1 promotes cell migration, invasion, and TGF-beta1-induced EMT and confers paclitaxel resistance in ovarian cancer","volume":"9","author":"Wu","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jbc.2026.111249_bib93","first-page":"4499","article-title":"ST3Gal3 confers paclitaxel-mediated chemoresistance in ovarian cancer cells by attenuating caspase-8\/3 signaling","volume":"20","author":"Zhang","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jbc.2026.111249_bib94","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012524","article-title":"alpha2,3-sialyltransferase ST3Gal III modulates pancreatic cancer cell motility and adhesion in vitro and enhances its metastatic potential in vivo","volume":"5","author":"Perez-Garay","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2026.111249_bib95","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s42003-024-05924-0","article-title":"ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of siglec ligands mediates anti-tumour immunity in prostate cancer","volume":"7","author":"Garnham","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.jbc.2026.111249_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.108368","article-title":"ST3GAL1 regulates cancer cell migration through crosstalk between EGFR and neuropilin-1 signaling","volume":"301","author":"Fan","year":"2025","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111249_bib97","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv326","article-title":"ST3GAL1-Associated transcriptomic program in glioblastoma tumor growth, invasion, and prognosis","volume":"108","author":"Chong","year":"2016","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jbc.2026.111249_bib98","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/ijgo.70292","article-title":"Targeting the ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) as a potential therapeutic strategy to overcome anti-VEGF resistance in endometrial cancer","volume":"171","author":"Liu","year":"2025","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.jbc.2026.111249_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2024.100821","article-title":"ST3GAL1 promotes malignant phenotypes in intrahepatic cholangiocarcinoma","volume":"23","author":"Chen","year":"2024","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.jbc.2026.111249_bib100","doi-asserted-by":"crossref","first-page":"26474","DOI":"10.1074\/jbc.M213223200","article-title":"Human alpha2,3-sialyltransferase (ST3Gal II) is a stage-specific embryonic antigen-4 synthase","volume":"278","author":"Saito","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111249_bib101","first-page":"280","article-title":"ST3GAL2 knock-down decreases tumoral character of colorectal cancer cells in vitro and in vivo","volume":"12","author":"Deschuyter","year":"2022","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.jbc.2026.111249_bib102","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s10719-024-10173-8","article-title":"MUC1 expression is associated with ST3GAL2 and negatively correlated with the androgen receptor in castration-resistant prostate cancer","volume":"41","author":"Nakanishi","year":"2024","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.jbc.2026.111249_bib103","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adg3481","article-title":"Integrated in vivo functional screens and multiomics analyses identify alpha-2,3-sialylation as essential for melanoma maintenance","volume":"11","author":"Agrawal","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jbc.2026.111249_bib104","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adr0277","article-title":"Screening the human miRNA interactome reveals coordinated up-regulation in melanoma, adding bidirectional regulation to miRNA networks","volume":"11","author":"Jame-Chenarboo","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jbc.2026.111249_bib105","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1349-7006.2004.tb03219.x","article-title":"Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesis","volume":"95","author":"Kannagi","year":"2004","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jbc.2026.111249_bib106","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/bs.acr.2022.07.001","article-title":"The biology of E-selectin ligands in leukemogenesis","volume":"157","author":"Ales","year":"2023","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.jbc.2026.111249_bib107","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.3892\/or.2016.5180","article-title":"ST3Gal III modulates breast cancer cell adhesion and invasion by altering the expression of invasion-related molecules","volume":"36","author":"Cui","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.jbc.2026.111249_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2025.167900","article-title":"Sialyltransferase ST3GAL4 directs a dual mechanism to promote pancreatic ductal adenocarcinoma progression by regulating endoplasmic reticulum stress and mitochondrial homeostasis","volume":"1871","author":"Zeng","year":"2025","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.jbc.2026.111249_bib109","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10719-023-10113-y","article-title":"ST3GalIV drives SLeX biosynthesis in gastrointestinal cancer cells and associates with cancer cell motility","volume":"40","author":"Costa","year":"2023","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.jbc.2026.111249_bib110","article-title":"The role of ST3GAL4 in glioma malignancy, macrophage infiltration, and prognostic outcomes","volume":"10","author":"Zheng","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.jbc.2026.111249_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216762","article-title":"Sialyltransferase ST3GAL4 confers osimertinib resistance and offers strategies to overcome resistance in non-small cell lung cancer","volume":"588","author":"Han","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jbc.2026.111249_bib112","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s12013-022-01091-3","article-title":"Role of a disease-associated ST3Gal-4 in non-small cell lung cancer","volume":"80","author":"Singh","year":"2022","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.jbc.2026.111249_bib113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13577-024-01137-z","article-title":"ST3GAL4 promotes tumorigenesis in breast cancer by enhancing aerobic glycolysis","volume":"38","author":"Chen","year":"2024","journal-title":"Hum. Cell"},{"key":"10.1016\/j.jbc.2026.111249_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112569","article-title":"Identification and validation of sialyltransferase ST3Gal5 in bladder cancer through bioinformatics and experimental analysis","volume":"138","author":"Jian","year":"2024","journal-title":"Int. Immunopharmacol"},{"key":"10.1016\/j.jbc.2026.111249_bib115","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12935-025-03640-1","article-title":"Comprehensive analysis of alpha2,3-sialyltransferases as prognostic biomarkers and immunotherapy targets in kidney renal clear cell carcinoma","volume":"25","author":"Jian","year":"2025","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.jbc.2026.111249_bib116","doi-asserted-by":"crossref","first-page":"828","DOI":"10.3892\/ol.2020.11597","article-title":"Downregulation of ST3GAL5 is associated with muscle invasion, high grade and a poor prognosis in patients with bladder cancer","volume":"20","author":"Ouyang","year":"2020","journal-title":"Oncol Lett."},{"key":"10.1016\/j.jbc.2026.111249_bib117","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1182\/blood-2014-03-560862","article-title":"The sialyltransferase ST3GAL6 influences homing and survival in multiple myeloma","volume":"124","author":"Glavey","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jbc.2026.111249_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.136519","article-title":"Overexpression of sialyl Lewis(a) carrying mucin-type glycoprotein in prostate cancer cell line contributes to aggressiveness and metastasis","volume":"281","author":"J","year":"2024","journal-title":"Int. J. Biol. Macromol"},{"key":"10.1016\/j.jbc.2026.111249_bib119","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1158\/0008-5472.CAN-12-3424","article-title":"ST6Gal-I protein expression is upregulated in human epithelial tumors and correlates with stem cell markers in normal tissues and colon cancer cell lines","volume":"73","author":"Swindall","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2026.111249_bib120","doi-asserted-by":"crossref","first-page":"629","DOI":"10.5009\/gnl.2013.7.6.629","article-title":"Increasing the \u03b1 2, 6 sialylation of glycoproteins may contribute to metastatic spread and therapeutic resistance in colorectal cancer","volume":"7","author":"Park","year":"2013","journal-title":"Gut Liver"},{"key":"10.1016\/j.jbc.2026.111249_bib121","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1757-2215-6-25","article-title":"ST6Gal-I sialyltransferase confers cisplatin resistance in ovarian tumor cells","volume":"6","author":"Schultz","year":"2013","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.jbc.2026.111249_bib122","doi-asserted-by":"crossref","first-page":"65374","DOI":"10.18632\/oncotarget.11699","article-title":"ST6Gal-I overexpression facilitates prostate cancer progression via the PI3K\/Akt\/GSK-3beta\/beta-catenin signaling pathway","volume":"7","author":"Wei","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbc.2026.111249_bib123","first-page":"983","article-title":"ST6GAL1: a key player in cancer","volume":"18","author":"Garnham","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.jbc.2026.111249_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105163","article-title":"Sialic acid blockade inhibits the metastatic spread of prostate cancer to bone","volume":"104","author":"Hodgson","year":"2024","journal-title":"eBioMedicine"},{"key":"10.1016\/j.jbc.2026.111249_bib125","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/path.6152","article-title":"ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression","volume":"261","author":"Scott","year":"2023","journal-title":"J. Pathol."},{"key":"10.1016\/j.jbc.2026.111249_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2024.100984","article-title":"ST6GAL1 is associated with poor response to chemoradiation in rectal cancer","volume":"51","author":"Smithson","year":"2024","journal-title":"Neoplasia"},{"key":"10.1016\/j.jbc.2026.111249_bib127","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.161563","article-title":"ST6GAL1 sialyltransferase promotes acinar to ductal metaplasia and pancreatic cancer progression","volume":"8","author":"Bhalerao","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.jbc.2026.111249_bib128","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.158799","article-title":"alpha2,6 sialylation mediated by ST6GAL1 promotes glioblastoma growth","volume":"7","author":"Gc","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.jbc.2026.111249_bib129","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/glycob\/cwad051","article-title":"Role of the ST6GAL1 sialyltransferase in regulating ovarian cancer cell metabolism","volume":"33","author":"Jones","year":"2023","journal-title":"Glycobiology"},{"key":"10.1016\/j.jbc.2026.111249_bib130","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1038\/s41417-022-00485-y","article-title":"Extracellular sialyltransferase st6gal1 in breast tumor cell growth and invasiveness","volume":"29","author":"Hait","year":"2022","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.jbc.2026.111249_bib131","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.108043","article-title":"Apoptotic signaling by TNFR1 is inhibited by the alpha2-6 sialylation, but not alpha2-3 sialylation, of the TNFR1 N-glycans","volume":"301","author":"Hwang","year":"2025","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111249_bib132","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2147\/JIR.S437291","article-title":"Downregulation of ST6GAL2 correlates to liver inflammation and predicts adverse prognosis in hepatocellular carcinoma","volume":"17","author":"Liu","year":"2024","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.jbc.2026.111249_bib133","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12935-023-02983-x","article-title":"Integrative analysis of the ST6GALNAC family identifies GATA2-upregulated ST6GALNAC5 as an adverse prognostic biomarker promoting prostate cancer cell invasion","volume":"23","author":"Li","year":"2023","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.jbc.2026.111249_bib134","doi-asserted-by":"crossref","DOI":"10.1172\/JCI186863","article-title":"ST6GalNAc-I regulates tumor cell sialylation via NECTIN2\/MUC5AC-mediated immunosuppression and angiogenesis in non-small cell lung cancer","volume":"135","author":"Appadurai","year":"2025","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jbc.2026.111249_bib135","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s13258-023-01445-y","article-title":"ST6GALNAC1 promotes the invasion and migration of breast cancer cells via the EMT pathway","volume":"45","author":"Luo","year":"2023","journal-title":"Genes Genomics"},{"key":"10.1016\/j.jbc.2026.111249_bib136","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0311212","article-title":"Differential expression of ST6GALNAC1 and ST6GALNAC2 and their clinical relevance to colorectal cancer progression","volume":"19","author":"Ahmad","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2026.111249_bib137","article-title":"Analysis of cancer-associated glycosyltransferases reveals novel targets of non-small cell lung cancer pathogenesis","volume":"15","author":"Liu","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jbc.2026.111249_bib138","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-37363-y","article-title":"Reduction in disialyl-T antigen levels in mice deficient for both St6galnac3 and St6galnac4 results in blood filling of lymph nodes","volume":"13","author":"Fuseya","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2026.111249_bib139","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2215376120","article-title":"MYC-driven synthesis of siglec ligands is a glycoimmune checkpoint","volume":"120","author":"Smith","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.111249_bib140","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1186\/s12967-023-04191-7","article-title":"ST6GALNAC4 promotes hepatocellular carcinogenesis by inducing abnormal glycosylation","volume":"21","author":"Man","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jbc.2026.111249_bib141","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1042\/BJ20061118","article-title":"Identification and expression of a sialyltransferase responsible for the synthesis of disialylgalactosylgloboside in normal and malignant kidney cells: downregulation of ST6GalNAc VI in renal cancers","volume":"402","author":"Senda","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.jbc.2026.111249_bib142","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.19422","article-title":"Sialyltransferase-related genes as predictive factors for therapeutic response and prognosis in cervical cancer","volume":"13","author":"Shao","year":"2025","journal-title":"PeerJ"},{"key":"10.1016\/j.jbc.2026.111249_bib143","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12935-025-03790-2","article-title":"The GD3 ganglioside promotes cell growth, plasticity and chemotherapy resistance of human glioblastoma cancer stem cells","volume":"25","author":"Hein","year":"2025","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.jbc.2026.111249_bib144","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1038\/s41388-025-03432-x","article-title":"GD3 synthase drives resistance to p53-induced apoptosis in breast cancer by modulating mitochondrial function","volume":"44","author":"Anand","year":"2025","journal-title":"Oncogene"},{"key":"10.1016\/j.jbc.2026.111249_bib145","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.3390\/genes11121436","article-title":"Comprehensive transcriptomic analysis identifies ST8SIA1 as a survival-related sialyltransferase gene in breast cancer","volume":"11","author":"Kan","year":"2020","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.jbc.2026.111249_bib146","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.3390\/cancers14051299","article-title":"Role of GD3 synthase ST8Sia I in cancers","volume":"14","author":"Kasprowicz","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jbc.2026.111249_bib147","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2174\/156800912803251225","article-title":"Polysialyltransferase: a new target in metastatic cancer","volume":"12","author":"Falconer","year":"2012","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.jbc.2026.111249_bib148","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2024.108703","article-title":"Diffuse tumors: molecular determinants shared by different cancer types","volume":"178","author":"Li","year":"2024","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.jbc.2026.111249_bib149","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s12672-025-02566-4","article-title":"Sialyltransferase gene signature as a predictor of prognosis and therapeutic response in kidney renal clear cell carcinoma","volume":"16","author":"Liu","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.jbc.2026.111249_bib150","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.3390\/cancers11091267","article-title":"Glycolipids recognized by A2B5 antibody promote proliferation, migration, and clonogenicity in glioblastoma cells","volume":"11","author":"Baeza-Kallee","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jbc.2026.111249_bib151","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1158\/2326-6066.CIR-20-0834","article-title":"ST8Sia6 promotes tumor growth in mice by inhibiting immune responses","volume":"9","author":"Friedman","year":"2021","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.jbc.2026.111249_bib152","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3390\/jpm12030401","article-title":"Bioinformatics analyses identify the therapeutic potential of ST8SIA6 for colon cancer","volume":"12","author":"Ko","year":"2022","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.jbc.2026.111249_bib153","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nri3737","article-title":"Siglec-mediated regulation of immune cell function in disease","volume":"14","author":"Macauley","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jbc.2026.111249_bib154","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1146\/annurev-immunol-102419-035900","article-title":"Siglecs as immune cell checkpoints in disease","volume":"38","author":"Duan","year":"2020","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jbc.2026.111249_bib155","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41573-020-00093-1","article-title":"The clinical impact of glycobiology: targeting selectins, siglecs and mammalian glycans","volume":"20","author":"Smith","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jbc.2026.111249_bib156","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1021\/acschembio.1c00501","article-title":"Carbohydrate sulfation as a mechanism for fine-tuning siglec ligands","volume":"16","author":"Jung","year":"2021","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jbc.2026.111249_bib157","doi-asserted-by":"crossref","DOI":"10.1016\/j.carres.2025.109502","article-title":"Carbohydrate sulfation as a critical modulator of siglec-sialoglycan interactions","volume":"553","author":"Jung","year":"2025","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.jbc.2026.111249_bib158","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/glycob\/cwab068","article-title":"Deacetylated sialic acids modulates immune mediated cytotoxicity via the sialic acid-siglec pathway","volume":"31","author":"Grabenstein","year":"2021","journal-title":"Glycobiology"},{"key":"10.1016\/j.jbc.2026.111249_bib159","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1570121","article-title":"CD16 and siglec expression refine the phenotypic heterogeneity of steady-state myeloid-derived suppressor cells","volume":"15","author":"St Laurent","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jbc.2026.111249_bib160","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/s41423-024-01142-0","article-title":"Engagement of sialylated glycans with siglec receptors on suppressive myeloid cells inhibits anticancer immunity via CCL2","volume":"21","author":"Wieboldt","year":"2024","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.jbc.2026.111249_bib161","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2022.101112","article-title":"Siglec receptors as new immune checkpoints in cancer","volume":"90","author":"Stanczak","year":"2023","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.jbc.2026.111249_bib162","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-012391","article-title":"Tumor glyco-immunology, glyco-immune checkpoints and immunotherapy","volume":"13","author":"Pinho","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jbc.2026.111249_bib163","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.trecan.2023.11.009","article-title":"Targeting myeloid cells for cancer immunotherapy: Siglec-7\/9\/10\/15 and their ligands","volume":"10","author":"Boelaars","year":"2024","journal-title":"Trends Cancer"},{"key":"10.1016\/j.jbc.2026.111249_bib164","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1080\/14728222.2025.2557281","article-title":"Disrupting Siglec-mediated interactions to develop immunotherapies for cancer treatment","volume":"29","author":"Laubli","year":"2025","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.jbc.2026.111249_bib165","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2024.101893","article-title":"Sialic acid and Siglec receptors in tumor immunity and immunotherapy","volume":"74-75","author":"Mantuano","year":"2024","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.jbc.2026.111249_bib166","doi-asserted-by":"crossref","first-page":"6211","DOI":"10.1038\/s41467-022-34001-5","article-title":"Blood monocyte-derived CD169(+) macrophages contribute to antitumor immunity against glioblastoma","volume":"13","author":"Kim","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2026.111249_bib167","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3390\/vaccines13030330","article-title":"Exploring CD169(+) macrophages as key targets for vaccination and therapeutic interventions","volume":"13","author":"Bouma","year":"2025","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jbc.2026.111249_bib168","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.bj.2019.07.010","article-title":"Coordinated roles for glycans in regulating the inhibitory function of CD22 on B cells","volume":"42","author":"Enterina","year":"2019","journal-title":"Biomed. J."},{"key":"10.1016\/j.jbc.2026.111249_bib169","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/s41467-017-00836-6","article-title":"Molecular basis of human CD22 function and therapeutic targeting","volume":"8","author":"Ereno-Orbea","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2026.111249_bib170","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0140-6736(24)00746-3","article-title":"CD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy: a dose-finding phase 1 study","volume":"404","author":"Frank","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jbc.2026.111249_bib171","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13024-024-00734-8","article-title":"Alzheimer's disease associated isoforms of human CD33 distinctively modulate microglial cell responses in 5XFAD mice","volume":"19","author":"Eskandari-Sedighi","year":"2024","journal-title":"Mol. Neurodegener"},{"key":"10.1016\/j.jbc.2026.111249_bib172","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12885-021-09116-5","article-title":"Targeting CD33 for acute myeloid leukemia therapy","volume":"22","author":"Liu","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jbc.2026.111249_bib173","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242417141","article-title":"SIGLEC-5\/14 inhibits CD11b\/CD18 integrin activation and neutrophil-mediated tumor cell cytotoxicity","volume":"24","author":"Bouti","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2026.111249_bib174","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/imm.13470","article-title":"Siglec-5 is an inhibitory immune checkpoint molecule for human T cells","volume":"166","author":"Vuchkovska","year":"2022","journal-title":"Immunology"},{"key":"10.1016\/j.jbc.2026.111249_bib175","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1038\/s41467-023-38030-6","article-title":"Siglec-6 mediates the uptake of extracellular vesicles through a noncanonical glycolipid binding pocket","volume":"14","author":"Schmidt","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2026.111249_bib176","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.euf.2021.06.001","article-title":"Siglec-6 as a new potential immune checkpoint for bladder cancer patients","volume":"8","author":"Benmerzoug","year":"2022","journal-title":"Eur. Urol. Focus"},{"key":"10.1016\/j.jbc.2026.111249_bib177","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.3389\/fimmu.2018.02138","article-title":"Functional inhibitory Siglec-6 is upregulated in human colorectal cancer-associated mast cells","volume":"9","author":"Yu","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jbc.2026.111249_bib178","doi-asserted-by":"crossref","first-page":"5180","DOI":"10.1038\/s41467-024-48678-3","article-title":"Siglec-6 as a therapeutic target for cell migration and adhesion in chronic lymphocytic leukemia","volume":"15","author":"Nunes","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2026.111249_bib179","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1021\/acscentsci.3c00969","article-title":"Dissecting the ability of siglecs to antagonize fcgamma receptors","volume":"10","author":"McCord","year":"2024","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.jbc.2026.111249_bib180","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.840388","article-title":"Molecular basis and role of Siglec-7 ligand expression on chronic lymphocytic leukemia B cells","volume":"13","author":"Chang","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jbc.2026.111249_bib181","article-title":"Insights into Siglec-7 binding to gangliosides: NMR protein assignment and the impact of ligand flexibility","volume":"12","author":"Di Carluccio","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.jbc.2026.111249_bib182","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105579","article-title":"The glycoimmune checkpoint receptor Siglec-7 interacts with T-cell ligands and regulates T-cell activation","volume":"300","author":"Stewart","year":"2024","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111249_bib183","doi-asserted-by":"crossref","DOI":"10.1172\/JCI180282","article-title":"Sialylated glycoproteins suppress immune cell killing by binding to Siglec-7 and Siglec-9 in prostate cancer","volume":"134","author":"Wen","year":"2024","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.jbc.2026.111249_bib184","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1524","article-title":"Siglec-7 and Siglec-9 expression in primary triple negative and oestrogen receptor positive breast cancer and in vitro signalling","volume":"13","author":"van Houtum","year":"2024","journal-title":"Clin. Transl Immunol."},{"key":"10.1016\/j.jbc.2026.111249_bib185","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1038\/s41467-021-21550-4","article-title":"Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the siglec receptors Siglec-7 and Siglec-9","volume":"12","author":"Rodriguez","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2026.111249_bib186","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s42003-024-06087-8","article-title":"Pancreatic cancer-associated fibroblasts modulate macrophage differentiation via sialic acid-siglec interactions","volume":"7","author":"Boelaars","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.jbc.2026.111249_bib187","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.3390\/ijms22042000","article-title":"First evidence for a role of Siglec-8 in breast cancer","volume":"22","author":"Trebo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2026.111249_bib188","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1476-4598-9-118","article-title":"Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes","volume":"9","author":"Belisle","year":"2010","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jbc.2026.111249_bib189","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41375-024-02454-w","article-title":"The gycosyltransferase ST3GAL4 drives immune evasion in acute myeloid leukemia by synthesizing ligands for the glyco-immune checkpoint receptor Siglec-9","volume":"39","author":"Krishnamoorthy","year":"2025","journal-title":"Leukemia"},{"key":"10.1016\/j.jbc.2026.111249_bib190","doi-asserted-by":"crossref","first-page":"4912","DOI":"10.1172\/JCI120612","article-title":"Self-associated molecular patterns mediate cancer immune evasion by engaging siglecs on T cells","volume":"128","author":"Stanczak","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jbc.2026.111249_bib191","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1178817","article-title":"Disruption of the sialic acid\/Siglec-9 axis improves antibody-mediated neutrophil cytotoxicity towards tumor cells","volume":"14","author":"Lustig","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jbc.2026.111249_bib192","doi-asserted-by":"crossref","first-page":"eadf5302","DOI":"10.1126\/scitranslmed.adf5302","article-title":"Targeting the Siglec-sialic acid axis promotes antitumor immune responses in preclinical models of glioblastoma","volume":"15","author":"Schmassmann","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jbc.2026.111249_bib193","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/s43018-023-00598-9","article-title":"Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response","volume":"4","author":"Mei","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.jbc.2026.111249_bib194","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41586-019-1456-0","article-title":"CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy","volume":"572","author":"Barkal","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2026.111249_bib195","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009404","article-title":"Identification of Siglec-10 as a new dendritic cell checkpoint for cervical cancer immunotherapy","volume":"12","author":"Wang","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jbc.2026.111249_bib196","article-title":"Targeted release of a bispecific fusion protein SIRPalpha\/Siglec-10 by oncolytic adenovirus reinvigorates tumor-associated macrophages to improve therapeutic outcomes in solid tumors","volume":"13","author":"Zhang","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jbc.2026.111249_bib197","article-title":"The unique molecular recognition features of Siglec-10: structural insights into sialoglycan and antibody interactions","author":"Sobczak","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.jbc.2026.111249_bib198","article-title":"CRISPR activation screens map the genomic landscape of cancer glycome remodeling","author":"Daly","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.jbc.2026.111249_bib199","doi-asserted-by":"crossref","first-page":"751","DOI":"10.15252\/embj.201695581","article-title":"Paired siglec receptors generate opposite inflammatory responses to a human-specific pathogen","volume":"36","author":"Schwarz","year":"2017","journal-title":"EMBO J."},{"key":"10.1016\/j.jbc.2026.111249_bib200","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/glycob\/cwaa082","article-title":"Human-specific microglial Siglec-11 transcript variant has the potential to affect polysialic acid-mediated brain functions at a distance","volume":"31","author":"Hane","year":"2021","journal-title":"Glycobiology"},{"key":"10.1016\/j.jbc.2026.111249_bib201","doi-asserted-by":"crossref","first-page":"154","DOI":"10.15252\/emmm.201606627","article-title":"Polysialic acid blocks mononuclear phagocyte reactivity, inhibits complement activation, and protects from vascular damage in the retina","volume":"9","author":"Karlstetter","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.jbc.2026.111249_bib202","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1016\/j.cell.2021.04.023","article-title":"Small RNAs are modified with N-glycans and displayed on the surface of living cells","volume":"184","author":"Flynn","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2026.111249_bib203","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010162","article-title":"SIGLEC11 promotes M2 macrophage polarization through AKT-mTOR signaling and facilitates the progression of gastric cancer","volume":"13","author":"Yin","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jbc.2026.111249_bib204","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1158\/1078-0432.CCR-22-1488","article-title":"Proinflammatory macrophage activation by the polysialic Acid-Siglec-16 axis is linked to increased survival of patients with glioblastoma","volume":"29","author":"Thiesler","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jbc.2026.111249_bib205","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1038\/s41467-023-39119-8","article-title":"Structural insights into Siglec-15 reveal glycosylation dependency for its interaction with T cells through integrin CD11b","volume":"14","author":"Lenza","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2026.111249_bib206","first-page":"44","article-title":"Siglec-15 recognition of sialoglycans on tumor cell lines can occur independently of sialyl Tn antigen expression","volume":"31","author":"Murugesan","year":"2021","journal-title":"Glycobiology"},{"key":"10.1016\/j.jbc.2026.111249_bib207","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202411863","article-title":"Enzymatic synthesis of Disialyllacto-N-Tetraose (DSLNT) and related human milk oligosaccharides reveals broad siglec recognition of the atypical Neu5Acalpha2-6GlcNAc motif","volume":"63","author":"Bao","year":"2024","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.jbc.2026.111249_bib208","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/s41591-019-0374-x","article-title":"Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy","volume":"25","author":"Wang","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.jbc.2026.111249_bib209","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41417-023-00713-z","article-title":"Siglec-15 on macrophages suppress the immune microenvironment in patients with PD-L1 negative non-metastasis lung adenocarcinoma","volume":"31","author":"Huang","year":"2024","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.jbc.2026.111249_bib210","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.7150\/jca.87618","article-title":"Tumor stroma Siglec15 expression is a poor prognosis predictor in colon adenocarcinoma","volume":"14","author":"Zhan","year":"2023","journal-title":"J. Cancer"},{"key":"10.1016\/j.jbc.2026.111249_bib211","article-title":"Siglec-15\/sialic acid axis as a central glyco-immune checkpoint in breast cancer bone metastasis","volume":"121","author":"Wang","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.111249_bib212","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/glycob\/cwx105","article-title":"Selectins cancer immun","volume":"28","author":"Borsig","year":"2018","journal-title":"Glycobiology"},{"key":"10.1016\/j.jbc.2026.111249_bib213","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10585-007-9096-4","article-title":"Selectins and selectin ligands in extravasation of cancer cells and organ selectivity of metastasis","volume":"25","author":"Gout","year":"2008","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.jbc.2026.111249_bib214","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.2741\/3909","article-title":"Interactions between endothelial selectins and cancer cells regulate metastasis","volume":"16","author":"St Hill","year":"2011","journal-title":"Front. Biosci."},{"key":"10.1016\/j.jbc.2026.111249_bib215","doi-asserted-by":"crossref","first-page":"7683","DOI":"10.1158\/0008-5472.CAN-11-1139","article-title":"Selectin ligand sialyl-Lewis x antigen drives metastasis of hormone-dependent breast cancers","volume":"71","author":"Julien","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2026.111249_bib216","doi-asserted-by":"crossref","first-page":"7431","DOI":"10.7150\/thno.33858","article-title":"Carcinoembryonic antigen carrying SLe(X) as a new biomarker of more aggressive gastric carcinomas","volume":"9","author":"Gomes","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.jbc.2026.111249_bib217","doi-asserted-by":"crossref","DOI":"10.3389\/frhem.2024.1360149","article-title":"Hypersialylation and multiple myeloma","volume":"3","author":"O\u2019Dwyer","year":"2024","journal-title":"Front. Hematol."},{"key":"10.1016\/j.jbc.2026.111249_bib218","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/1878-0261.13733","article-title":"E-selectin affinity glycoproteomics reveals neuroendocrine proteins and the secretin receptor as a poor-prognosis signature in colorectal cancer","volume":"19","author":"Cotton","year":"2025","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.jbc.2026.111249_bib219","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2024.102454","article-title":"Advances in understanding and exploiting Siglec-glycan interactions","volume":"80","author":"Jame-Chenarboo","year":"2024","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.jbc.2026.111249_bib220","doi-asserted-by":"crossref","first-page":"5091","DOI":"10.1038\/s41467-020-18907-6","article-title":"A versatile soluble siglec scaffold for sensitive and quantitative detection of glycan ligands","volume":"11","author":"Rodrigues","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2026.111249_bib221","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/978-1-0716-3151-5_13","article-title":"Flow cytometry-based detection of siglec ligands","volume":"2657","author":"Schmidt","year":"2023","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jbc.2026.111249_bib222","doi-asserted-by":"crossref","DOI":"10.1002\/cpz1.949","article-title":"Quantitative analysis of siglec ligands by flow cytometry","volume":"3","author":"Chang","year":"2023","journal-title":"Curr. Protoc."},{"key":"10.1016\/j.jbc.2026.111249_bib223","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1016\/j.chembiol.2024.09.010","article-title":"The liquid lectin array detects compositional glycocalyx differences using multivalent DNA-encoded lectins on phage","volume":"31","author":"Lima","year":"2024","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.jbc.2026.111249_bib224","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adz8096","article-title":"An ultrasensitive and modular platform to detect siglec ligands and control immune cell function","volume":"11","author":"Jame-Chenarboo","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jbc.2026.111249_bib225","doi-asserted-by":"crossref","first-page":"29469","DOI":"10.1021\/jacs.4c08817","article-title":"Enzyme-sialylation-controlled chemical sulfation of glycan epitopes for decoding the binding of siglec ligands","volume":"146","author":"Ma","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jbc.2026.111249_bib226","doi-asserted-by":"crossref","first-page":"35042","DOI":"10.1021\/jacs.5c11949","article-title":"De Novo Chemoenzymatic Assembly of Complex Sulfated N-Glycans to Comprehensively Profile the Ligand Binding of Human Siglecs","volume":"147","author":"Ma","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jbc.2026.111249_bib227","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.tips.2015.06.008","article-title":"Therapeutic targeting of siglecs using Antibody- and glycan-based approaches","volume":"36","author":"Angata","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jbc.2026.111249_bib228","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1002\/anie.202005934","article-title":"Glycoengineering of NK cells with glycan ligands of CD22 and selectins for B-Cell lymphoma therapy","volume":"60","author":"Hong","year":"2021","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.jbc.2026.111249_bib229","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1021\/acscentsci.1c00064","article-title":"Modulation of Siglec-7 signaling via in situ-created high-affinity cis-Ligands","volume":"7","author":"Hong","year":"2021","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.jbc.2026.111249_bib230","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/s41467-018-03245-5","article-title":"Cell-based glycan arrays for probing glycan-glycan binding protein interactions","volume":"9","author":"Briard","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2026.111249_bib231","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1021\/acschembio.4c00677","article-title":"Understanding the glycosylation pathways involved in the biosynthesis of the sulfated glycan ligands for siglecs","volume":"20","author":"Jung","year":"2025","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jbc.2026.111249_bib232","doi-asserted-by":"crossref","first-page":"6206","DOI":"10.1111\/febs.15647","article-title":"Tools to study and target the Siglec-sialic acid axis in cancer","volume":"288","author":"Laubli","year":"2021","journal-title":"FEBS J."},{"key":"10.1016\/j.jbc.2026.111249_bib233","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107482","article-title":"Dissecting the abilities of murine siglecs to interact with gangliosides","volume":"300","author":"Schmidt","year":"2024","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111249_bib234","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/med.21407","article-title":"Advancement of sialyltransferase inhibitors: therapeutic challenges and opportunities","volume":"37","author":"Szabo","year":"2017","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jbc.2026.111249_bib235","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nchembio.999","article-title":"Global metabolic inhibitors of sialyl- and fucosyltransferases remodel the glycome","volume":"8","author":"Rillahan","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jbc.2026.111249_bib236","doi-asserted-by":"crossref","first-page":"35149","DOI":"10.1074\/jbc.M114.606517","article-title":"Systemic blockade of sialylation in mice with a global inhibitor of sialyltransferases","volume":"289","author":"Macauley","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111249_bib237","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.tibs.2016.03.007","article-title":"Sialic acid mimetics to target the sialic acid-siglec axis","volume":"41","author":"Bull","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.jbc.2026.111249_bib238","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1021\/acschembio.1c00868","article-title":"Structure-activity relationship of metabolic sialic acid inhibitors and labeling reagents","volume":"17","author":"Moons","year":"2022","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jbc.2026.111249_bib239","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1021\/acs.jmedchem.8b01757","article-title":"Potent metabolic sialylation inhibitors based on C-5-Modified fluorinated sialic acids","volume":"62","author":"Heise","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jbc.2026.111249_bib240","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1039\/D5CB00030K","article-title":"Synthesis of 4-azido sialic acid for testing against Siglec-7 and in metabolic oligosaccharide engineering","volume":"6","author":"Gray","year":"2025","journal-title":"RSC Chem. Biol."},{"key":"10.1016\/j.jbc.2026.111249_bib241","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202400088","article-title":"Synthesis of alpha-Hydroxy-1,2,3-Triazole-linked sialyltransferase inhibitors and evaluation of selectivity towards ST3GAL1, ST6GAL1 and ST8SIA2","volume":"19","author":"Szabo","year":"2024","journal-title":"ChemMedChem"},{"key":"10.1016\/j.jbc.2026.111249_bib242","article-title":"A rapid and sensitive MicroPlate assay (MPSA) using an alkyne-modified CMP-sialic acid donor to evaluate human sialyltransferase specificity","volume":"26","author":"Filipe","year":"2025","journal-title":"ChemBioChem"},{"key":"10.1016\/j.jbc.2026.111249_bib243","doi-asserted-by":"crossref","first-page":"28630","DOI":"10.1021\/jacs.4c10835","article-title":"A kinetic trapping approach for facile access to 3F(ax)Neu5Ac and a photo-cross-linkable sialyltransferase probe","volume":"146","author":"Kumawat","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jbc.2026.111249_bib244","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1488668","article-title":"Sialylation inhibition improves macrophage mediated tumor cell phagocytosis of breast cancer cells triggered by therapeutic antibodies of different isotypes","volume":"14","author":"Lustig","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jbc.2026.111249_bib245","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3324\/haematol.2018.212266","article-title":"Sialyltransferase inhibition leads to inhibition of tumor cell interactions with E-selectin, VCAM1, and MADCAM1, and improves survival in a human multiple myeloma mouse model","volume":"105","author":"Natoni","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.jbc.2026.111249_bib246","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1021\/acscentsci.5c00939","article-title":"A potent oral sialylation inhibitor augments the immunotherapy in pancreatic ductal adenocarcinoma","volume":"11","author":"Mou","year":"2025","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.jbc.2026.111249_bib247","doi-asserted-by":"crossref","first-page":"10974","DOI":"10.1021\/acs.joc.3c00956","article-title":"Synthesis of sialyl Lewis(X) mimetics with E- and P-Selectin binding properties and immunosuppressive activity","volume":"88","author":"Simard","year":"2023","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.jbc.2026.111249_bib248","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007805","article-title":"Unraveling the impact of sialic acids on the immune landscape and immunotherapy efficacy in pancreatic cancer","volume":"11","author":"Boelaars","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jbc.2026.111249_bib249","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1002\/ijc.70031","article-title":"Tumor desialylation surpasses anti-PD-L1 checkpoint therapy in restoring anti-tumor immunity in a murine model for colorectal cancer","volume":"157","author":"van der Haar Avila","year":"2025","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jbc.2026.111249_bib250","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112475","article-title":"Targeting stromal cell sialylation reverses T cell-mediated immunosuppression in the tumor microenvironment","volume":"42","author":"Egan","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.jbc.2026.111249_bib251","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1182\/bloodadvances.2021006805","article-title":"Targeting hypersialylation in multiple myeloma represents a novel approach to enhance NK cell-mediated tumor responses","volume":"6","author":"Daly","year":"2022","journal-title":"Blood Adv."},{"key":"10.1016\/j.jbc.2026.111249_bib252","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1158\/2326-6066.CIR-22-0366","article-title":"Targeting the siglec-sialic acid immune axis in cancer: current and future approaches","volume":"10","author":"Laubli","year":"2022","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.jbc.2026.111249_bib253","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00262-023-03606-0","article-title":"Targeting CD24\/Siglec-10 signal pathway for cancer immunotherapy: recent advances and future directions","volume":"73","author":"Li","year":"2024","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.jbc.2026.111249_bib254","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1158\/1535-7163.MCT-13-0279","article-title":"Targeting aberrant sialylation in cancer cells using a fluorinated sialic acid analog impairs adhesion, migration, and in vivo tumor growth","volume":"12","author":"Bull","year":"2013","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jbc.2026.111249_bib255","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1021\/acscentsci.5c00510","article-title":"Targeting sialidase to PD1 enhances T cell function and tumor control","volume":"11","author":"Garabedian","year":"2025","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.jbc.2026.111249_bib256","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202400402","article-title":"Detection strategies for sialic acid and sialoglycoconjugates","volume":"25","author":"Hunter","year":"2024","journal-title":"ChemBioChem"},{"key":"10.1016\/j.jbc.2026.111249_bib257","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/s41589-020-0622-x","article-title":"Targeted glycan degradation potentiates the anticancer immune response in vivo","volume":"16","author":"Gray","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jbc.2026.111249_bib258","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.immuni.2025.04.027","article-title":"Glycosylation-driven programs coordinate immunoregulatory and pro-angiogenic functions of myeloid-derived suppressor cells","volume":"58","author":"Blidner","year":"2025","journal-title":"Immunity"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925826001195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925826001195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T23:22:20Z","timestamp":1776381740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925826001195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":258,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0021925826001195"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2026.111249","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Writers and readers of sialylation in immunoregulation in cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2026.111249","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"111249"}}